Fixed-dose combinations and hypertension control in community-based practices application of the "keep-it-simple" principle

Hypertension

Volumn 53, Issue 4, 2009, Pages 598-599

  Egan, Brent M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; COMMUNITY HEALTH SERVICES; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PRIMARY HEALTH CARE;

EID: 64849103457     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.128678     Document Type: Editorial

References (10)

1. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SAE, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension. 2009;53: 646-653.
2. Neutel JB. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Curr Med Res Opin. 2008;24:2389-2401.
3. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication adherence: a meta-analysis. Am J Med. 2008;120:713-719.
4. Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Ann Rev Publ Health. 2007;28: 413-433.
5. Francke AL, Smit MC, de Veer AJE, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Making. 2008;8:38 (1-11).
6. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-1632.
7. Ong KL, Cheung BMYU, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
8. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005-2006. NCHS Data Brief. 2008;3:l-8.
9. Okonofua EC, Simpson K, Jesri A, Rehman S, Durkalski V, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47: 1-7.
10. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, for the ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiaze for hypertension in high-risk patients. N Engl J Med. 2008;359: 2417-2428.